Behcet's disease associated with myelodysplastic syndromes: A case report and a review of the literature

Cancer

Volumn 79, Issue 2, 1997, Pages 262-268

  Ohno, Eiji ^a   Ohtsuka, Eiichi ^a   Watanabe, Kouichirou ^a   Kohno, Toshirou ^a   Takeoka, Kaori ^a   Saburi, Yoshio ^a   Kikuchi, Hiroshi ^a   Nasu, Masaru ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Behcet's disease; chemiluminescence; myelodysplastic syndromes; reactive oxygen species; trisomy 8

Indexed keywords

LUMINOL; REACTIVE OXYGEN METABOLITE; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; FORMYLMETHIONYLLEUCYLPHENYLALANINE;

ADULT; ARTICLE; BEHCET DISEASE; BONE MARROW CELL; CASE REPORT; CHEMOLUMINESCENCE; CHROMOSOME ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENETIC PREDISPOSITION; HUMAN; HUMAN CELL; LEUKOCYTE ACTIVATION; MYELODYSPLASTIC SYNDROME; NEUTROPHIL; PRIORITY JOURNAL; SERUM FACTOR; TRISOMY 8; BLOOD; CHROMOSOME 8; DRUG EFFECT; METABOLISM; RECURRENT DISEASE; REFRACTORY ANEMIA; REVIEW; TRISOMY;

ADULT; ANEMIA, REFRACTORY; BEHCET SYNDROME; CHEMILUMINESCENT MEASUREMENTS; CHROMOSOMES, HUMAN, PAIR 8; FEMALE; HUMANS; INDICATORS AND REAGENTS; LUMINOL; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NEUTROPHILS; REACTIVE OXYGEN SPECIES; RECURRENCE; TRISOMY;

EID: 0030614672     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19970115)79:2<262::AID-CNCR9>3.0.CO;2-M     Document Type: Article

References (31)

1. International Study Group for Behçet's disease. Criteria for diagnosis of Behçet's disease. Lancet 1990;335:1078-80.
2. Niwa Y, Miyake S, Sakane T, Shingu M, Yokoyama M. Autooxidative damage in Behçet's disease-endothelial cell damage following the elevated oxygen radicals generated by stimulated neutrophils. Clin Exp lmmunol 1982;49:247-55.
3. Yuo A, Kitagawa S, Tetsuro O, Urabe A, Komatsu Y, Itoh S, et al. Recombinant human granulocyte colony-stimulating factor repairs the abnormalities of neutrophils in patients with myelodysplastic syndromes and chronic myelogenous leukemia. Blood 1987; 70:404 -11.
4. Boogaerts MA, Nelissen V, Roelant C, Goossens W. Blood neutrophil function in primary myelodysplastic syndromes. Br J Haematol 1983;55:217-27.
5. Tsurumi H, Shimazaki M, Takahashi T, Moriwaki H, Muto Y. Flow cytometric determination of active oxygen (hydroperoxide) produced by peripheral blood neutrophils in patients with hematological disorders. Int J Henuuol 1993; 57:213-9.
6. Martin S, Baldock SC, Ghoneim AA, Child JA. Defective neutrophil function and microbicidal mechanisms in the myelodysplastic disorders. J Clin Pathol 1983;36:1120-8.
7. Verhoef G, Boogaerts M. In vivo administration of granulocyte-macrophage colony stimulating factor enhances neutrophil function in patients with myelodysplastic syndromes. Br J Haematol 1991;79:177-84.
8. Bennet JM, Catovsky D, Daniel MT, Frandrin G, Galton DAG, Gralnick HR, et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982:51:189-95.
9. Nehashi Y, Torii Y, Yaguchi M, Itoh Y, Ohyashiki K, Toyama K. Incomplete-form of Behçet's disease in a case of monopathic myelodysplastic syndrome presenting as a thrombocytopenia. [in Japanese], Jpn J Clin Hematol 1988;29:1097-102.
10. Nakayama S, Ishikawa T, Yabe H, Nagai K. Refractory anemia complicated by Behçet's disease [in Japanese]. Jpn J Clin Hematol 1989;30:530-4.
11. Chyuma Y, Utsunomiya A, Saito T, Hanada S, Nishimata H, Arima T. Hemolytic anemia complicated with Behçet's disease and myelodysplastic syndrome [in Japanese]. Jpn J Clin Hematol 1992;33:333-7.
12. Takishita N, Horiuchi T, Hato T, Fujita S, Kobayashi Y. Myelodysplastic syndrome complicated with Behçet's disease [in Japanese]. Ehime Igaku 1991;11:39-43.
13. Molina M, Aguayo JL, Ortega G, de Paco M, Cuesta F, Agudo MD. Non-specific digestive ulcers and Behçet's disease [in Spanish], An Med Interna 1992;9:237-8.
14. Yoshizawa Y, Hirai A, Izaki S, Kitamura K. Behçet's disease associated with myelodysplastic disorder [in Japanese]. Hifu Rinsho 1992;34:1585-9.
15. Kageyama H, Hidaka T, Kondou S, Tamura K. Intestinal Behçet's disease associated with myelodysplastic syndrome [in Japanese]. Jpn J Clin Hematol 1993;34:1288.
16. Yano K, Eguchi K, Takashima H, Ida H, Sakai M, Shimada H, et al. Behçet's disease associated with myelodysplastic syndrome [in Japanese]. J Jpn Soc Intern Med 1995;84:112-4.
17. Horiike S, Taniwaki M, Misawa S, Abe T. Chromosome abnormalities and karyotypic evolution in 83 patients with myelodysplastic syndrome and predictive value for prognosis. Cancer 1988;62:1129-38.
18. Yunis JJ, Rydell RE, Oken MM, Arnesen MA, Mayer MG, Lobell M. Refined chromosome analysis as an independent prognostic indicator in de novo myelodysplastic syndromes. Blood 1986;67:1721-30.
19. Jacobs RH, Cornbleet MA, Vardiman JW, Larson RA, Le Beau MM, Rowley JD. Prognostic implications of morphology and karyotype in primary myelodysplastic syndromes. Blood 1986;67:1765-72.
20. Cheson BD, Christensen RL, Sperling R, Kohler BE, Babior BM. The origin of the chemiluminescence of phagocytosing granulocytes. J Clin Invest 1976;58:789-96.
21. Takahama H, Itoh R, Inoue-Komatsu C, Furusawa S, Takahashi H, Mizoguchi M. Granulocyte colony-stimulating factor (G-CSF) and granulocyte macrophage colony-stimulating factor (GM-CSF) in Behçet's disease. J Dermatol 1994;21:546-52.
22. Mege JL, Dilsen N, Sanguedolce V, Gul A, Bongrand P, Roux H, et al. Overproduction of monocyte derived tumor necrosis factor alpha, interleukin (IL) 6, IL-8 and increased neutrophil Superoxide generation in Behçet's disease. A comparative study with familial Mediterranean fever and healthy subjects. J Rheumatol 1993;20:1544-9.
23. Zwierzina H, Holzinger I, Gaggl S, Wolf H, Schollenberger S, Lam C, et al. Recombinant human interleukin-8 restores function in neutrophils from patients with myelodysplastic syndromes without stimulating myeloid progenitor cells. Scand J lmmunol 1993;37:322-8.
24. Weisbart RH, Kwan L, Golde DW, Gasson JC. Human GM-CSF primes neutrophils for enhanced oxidative metabolism in response to the major physiological chemoattractants. Blood 1987;69:18-21.
25. Yuo A, Kitagawa S, Suzuki I, Urabe A, Okabe T, Saito M, et al. Tumor necrosis factor as an activator of human granulocytes. J Immunol 1989;142:1678-84.
26. Yuo A, Kitagawa S, Ohsaka A, Ohta M, Miyazono K, Okabe T, et al. Recombinant human granulocyte colony-stimulating factor as an activator of human granulocyte:potentiation of response triggered by receptor-mediated agonists and stimulation of C3bi receptor expression and adherence. Blood 1989;74:2144-9.
27. Yuo A, Kitagawa S, Kasahara T, Matsushima K, Saito M, Takaku F. Stimulation and priming of human neutrophils by interleukin-8:cooperation with tumor necrosis factor and colony-stimulating factors. Blood 1991;78:2708-14.
28. Wozniak A, Betts WH, Murphy GA, Rokicinski M. Interleukin-8 primes human neutrophils for enhanced superoxide anion production. Immunology 1993;79:608-15.
29. Pauksen K, Elfman L, Ulfgren AK, Venge P. Serum levels of granulocyte-colony stimulating factor (G-CSF) in bacterial and viral infections, and in atypical pneumonia. Br J Haematol 1994;88:256-60.
30. Bokoch GM. Chemoattractant signaling and leukocyte activation. Blood 1995;6:1649-60.
31. Hirai H, Kobayashi Y, Mano H. A point mutation at codon 13 of the N-ras oncogene in myelodysplastic syndrome. Nature 1987;327:430.